Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ribeiro, Jennifer R."" wg kryterium: Autor


Tytuł :
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
Autorzy :
James, Nicole E.
Emerson, Jenna B.Aff1, Aff2
Borgstadt, Ashley D.Aff1, Aff2
Beffa, LindseyAff1, Aff2
Oliver, Matthew T.Aff1, Aff2
Hovanesian, Virginia
Urh, Anze
Singh, Rakesh K.
Rowswell-Turner, Rachael
DiSilvestro, Paul A.Aff1, Aff2
Ou, JoyceAff2, Aff6
Moore, Richard G.
Ribeiro, Jennifer R.Aff1, Aff2
Pokaż więcej
Źródło :
Scientific Reports. 10(1)
Czasopismo naukowe
Tytuł :
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.
Autorzy :
Moore, Richard G.
Kim, Kyu Kwang
Han, Alex
Yano, Naohiro
Ribeiro, Jennifer R.
Lokich, Elizabeth
Singh, Rakesh K.
Pokaż więcej
Temat :
CISPLATIN
AMMONIUM tetrathiomolybdate
EPIDERMAL growth factor receptors regulation
GYNECOLOGIC cancer
MITOGEN-activated protein kinases
CHEMOTHERAPY (Cancer)
CANCER treatment
Źródło :
Scientific Reports; 11/20/2015, p15911, 1p
Czasopismo naukowe
Tytuł :
Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes.
Autorzy :
James NE; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Beffa L; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Oliver MT; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Borgstadt AD; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Emerson JB; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Chichester CO; Department of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Yano N; Department of Surgery, Roger Williams Medical Center, Providence, RI, USA.
Freiman RN; Department of Molecular and Cell Biology and Biochemistry, Brown University, Providence, RI, USA.
DiSilvestro PA; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Ribeiro JR; Women and Infants Hospital, Department of Obstetrics and Gynecology, Program in Women's Oncology, Providence, RI, USA.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2019 May 21; Vol. 10 (36), pp. 3315-3327. Date of Electronic Publication: 2019 May 21 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.
Autorzy :
James NE; Division of Gynecologic Oncology, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.; Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.
Cantillo E; Division of Gynecologic Oncology, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.
Yano N; Department of Surgery, Roger Williams Medical Center, Boston University Medical School, Providence, RI, USA.
Chichester CO; Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.
DiSilvestro PA; Division of Gynecologic Oncology, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.; Division of Biology and Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Hovanesian V; Core Research Laboratories, Rhode Island Hospital, Providence, RI, USA.
Rao RSP; Biostatistics and Bioinformatics Division, Yenepoya Research Center, Yenepoya University, Mangalore, India.
Kim KK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Moore RG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Ahsan N; Center for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, RI, USA.; Division of Biology and Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Ribeiro JR; Division of Gynecologic Oncology, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.; Division of Biology and Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2019 Apr 26; Vol. 10 (31), pp. 2959-2972. Date of Electronic Publication: 2019 Apr 26 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.
Autorzy :
Kim KK; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Abelman S; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Yano N; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Ribeiro JR; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Singh RK; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Tipping M; Department of Biology, Providence College, Providence, RI, USA.
Moore RG; Molecular Therapeutics Laboratory, Program in Women's Oncology, Departments of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2015 Oct 15; Vol. 5, pp. 14296. Date of Electronic Publication: 2015 Oct 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Electron Transport Complex IV/*antagonists & inhibitors
Electron Transport Complex IV/*metabolism
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
Molybdenum/*pharmacology
Neoplasms/*metabolism
Cell Line, Tumor ; Cell Respiration/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Neoplasms/genetics ; Oxygen/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Proteolysis/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies